I'm still very new out here (and newly diagnosed), so I'm trying to avoid posting questions that have already been hit on this forum in the past. I saw some good content about this topic back in 2009, but I was wondering if anyone has gone through a --recent-- switch and what your experience was. I have really good coverage at the moment (thankfully) with a major carrier who is covering my initial Gleevec prescription, but I might have to endure a carrier switch within the next 12 months - this is already causing me some financial anxiety!
Some key questions (but I'm sure there are more to be considered):
** Are all of the major carriers providing reasonable coverage for the targeted therapies? For example, my carrier is charging me a $60 co-pay for a 90-day 400mg supply of Gleevec.
** Are major carriers (e.g., the ones that are typically engaged with large employers) covering new employees who are already diagnosed with CML and taking targeted therapies? Are folks seeing any pushback or outright denial of coverage for this scenario?
** Any feedback on carriers that are supporting small businesses (~ 2 - 50 employees) and how they are responding to new employees' coverage?
** Does anyone know if the new health reform law(s) impact a carrier switch for CMLers re: pre-existing condition?
I would appreciate any feedback folks have on recent experiences dealing with this.
Thanks so much,